The Future of 340B: What Hospitals and Rural Communities Need to Know
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
The Future of 340B: What Hospitals and Rural Communities Need to Know
-
Narrated by:
-
By:
About this listen
Major shifts to the 340B drug pricing program could be on the horizon, along with new regulations, legal battles and congressional scrutiny. In this Leadership Dialogue conversation, Tina Freese Decker, president and CEO of Corewell Health and 2025 AHA board chair, joins Aimee Kuhlman, vice president of advocacy grassroots and government relations at the AHA, and Paulette Davidson, president and CEO of Monument Health, to unpack what’s at stake. They explore potential regulatory changes for 340B, the lifeline it provides for rural hospitals, and how upcoming changes could alter the financial landscape for the hospitals that anchor their rural communities.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.